nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—SRD5A1—Androgen biosynthesis—CGA—conduct disorder	0.444	0.479	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of steroid hormones and vitamin D—CGA—conduct disorder	0.184	0.199	CbGpPWpGaD
Levonorgestrel—CYP19A1—FSH signaling pathway—CGA—conduct disorder	0.047	0.0507	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of steroid hormones and vitamin D—CGA—conduct disorder	0.0401	0.0432	CbGpPWpGaD
Levonorgestrel—Nandrolone decanoate—MAOA—conduct disorder	0.0325	0.454	CrCbGaD
Levonorgestrel—Testosterone Propionate—COMT—conduct disorder	0.0295	0.412	CrCbGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0189	0.0204	CbGpPWpGaD
Levonorgestrel—Testosterone—MAOA—conduct disorder	0.00966	0.135	CrCbGaD
Levonorgestrel—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00902	0.00972	CbGpPWpGaD
Levonorgestrel—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00857	0.00923	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CGA—conduct disorder	0.00842	0.00907	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.008	0.00862	CbGpPWpGaD
Levonorgestrel—AR—FOXA1 transcription factor network—EP300—conduct disorder	0.00716	0.00771	CbGpPWpGaD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.00696	0.0075	CbGpPWpGaD
Levonorgestrel—AR—Notch-mediated HES/HEY network—EP300—conduct disorder	0.00679	0.00732	CbGpPWpGaD
Levonorgestrel—AR—Regulation of Androgen receptor activity—EP300—conduct disorder	0.00617	0.00665	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00602	0.00649	CbGpPWpGaD
Levonorgestrel—ESR1—FOXM1 transcription factor network—EP300—conduct disorder	0.00573	0.00617	CbGpPWpGaD
Levonorgestrel—ESR1—FOXA1 transcription factor network—EP300—conduct disorder	0.00552	0.00594	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00532	0.00573	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00491	0.00529	CbGpPWpGaD
Levonorgestrel—CYP19A1—Biological oxidations—COMT—conduct disorder	0.00483	0.0052	CbGpPWpGaD
Levonorgestrel—CYP19A1—Biological oxidations—MAOA—conduct disorder	0.00479	0.00516	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metapathway biotransformation—COMT—conduct disorder	0.00476	0.00513	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.00444	0.00478	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00439	0.00473	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—EP300—conduct disorder	0.00436	0.0047	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00411	0.00442	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.00409	0.0044	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—EP300—conduct disorder	0.00408	0.00439	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—EP300—conduct disorder	0.0038	0.0041	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—COMT—conduct disorder	0.0038	0.0041	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—MAOA—conduct disorder	0.00377	0.00407	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00366	0.00394	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—POLR3A—conduct disorder	0.00342	0.00368	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00339	0.00365	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00267	0.00288	CbGpPWpGaD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00263	0.00284	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—POLR3A—conduct disorder	0.0026	0.0028	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—EP300—conduct disorder	0.0026	0.0028	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CGA—conduct disorder	0.00233	0.00251	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.0023	0.00247	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00221	0.00238	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00206	0.00222	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—POLR3A—conduct disorder	0.002	0.00216	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—WASF1—conduct disorder	0.00187	0.00201	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CGA—conduct disorder	0.00183	0.00197	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.0017	0.00184	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—EP300—conduct disorder	0.00163	0.00176	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00141	0.00152	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.0014	0.00151	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00139	0.0015	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CGA—conduct disorder	0.00137	0.00147	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—DRD4—conduct disorder	0.00131	0.00141	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—WASF1—conduct disorder	0.0011	0.00118	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HTR2A—conduct disorder	0.000852	0.000918	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—COMT—conduct disorder	0.000826	0.000889	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MAOA—conduct disorder	0.00082	0.000883	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000795	0.000856	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DRD4—conduct disorder	0.000767	0.000826	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CGA—conduct disorder	0.000534	0.000575	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR2A—conduct disorder	0.0005	0.000539	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EP300—conduct disorder	0.000452	0.000486	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—EP300—conduct disorder	0.000354	0.000381	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EP300—conduct disorder	0.000265	0.000285	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—COMT—conduct disorder	0.000241	0.00026	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MAOA—conduct disorder	0.000239	0.000258	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—EP300—conduct disorder	0.000103	0.000111	CbGpPWpGaD
